Springworks Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Connecticut, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Washington Blvd, Stamford, Connectic...Phone Number
(203) 883-9490Website
www.springworkstx.comRevenue
$191.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
4
3
1
1
1
About Springworks Therapeutics
Founded in 2017. SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that identifies and advances promising science. It pioneers efficient pathways for drug development and serves patients with rare diseases and cancer. SpringWorks Therapeutics is headquartered in Stamford, Connecticut.Explore more
Springworks Therapeutics Org Chart
UI
Head Worldwide Medical Affairs & Member Leade...
DK
Global Patient Advocacy Senior Director
SS
Global Senior Director, Medical Research Oper...
JF
Senior Director, US Medical Science Liaison T...
MO
Senior Director, Clinical Pharmacology
GF
Senior Director, Toxicology
SD
Global Director, Medical Research
AK
Global Medical Director, Pharmacovigilance
MN
Senior Medical Director
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Springworks Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Springworks Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Springworks Therapeutics
Click to see if Springworks Therapeutics had a recent Job posting/layoffs
Check if Springworks Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Springworks Therapeutics has new funding data
Product Launch: Get notified when Springworks Therapeutics launches new products
Springworks Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Springworks Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Springworks Therapeutics
Compare insights from companies similar to Springworks Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Springworks Therapeutics
$191.6M
201-500
Private
$300M
2017
NL
Nicole LeedomVice President, Clinical Operations
Company Profile Activity
Activity Insights
Springworks Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Springworks Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Springworks Therapeutics.
Springworks Therapeutics financials insights
Gather financial insights about Springworks Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$75M
Share Placement
$225M
Springworks Therapeutics Tech Stack
A closer look at the technologies used by Springworks Therapeutics
Most Recent Scoops
Person-Based
Public Relations
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Springworks Therapeutics News & Media
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
– Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and consistent safety profile –European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumorsMerck KGaA's Strategic Debt Financing and Acquisition of SpringWorks Therapeutics
Merck KGaA's Strategic Debt Financing and Acquisition of SpringWorks Therapeutics: A High-Conviction Play in Rare Disease InnovationEuropean Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – – EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Springworks Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2017. SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that identifies and advances promising science. It pioneers efficient pathways for drug development and serves patients with rare diseases and cancer. SpringWorks Therapeutics is headquartered in Stamford, Connecticut.... Read More
